30328325|t|Inhibition of miR-128 Abates Abeta-Mediated Cytotoxicity by Targeting PPAR-gamma via NF-kappaB Inactivation in Primary Mouse Cortical Neurons and Neuro2a Cells.
30328325|a|PURPOSE: Alzheimer's disease (AD) is the sixth most common cause of death in the United States. MicroRNAs have been identified as vital players in neurodegenerative diseases, including AD. microRNA-128 (miR-128) has been shown to be dysregulated in AD. This study aimed to explore the roles and molecular mechanisms of miR-128 in AD progression. MATERIALS AND METHODS: Expression patterns of miR-128 and peroxisome proliferator-activated receptor gamma (PPAR-gamma) messenger RNA in clinical samples and cells were measured using RT-qPCR assay. PPAR-gamma protein levels were determined by Western blot assay. Cell viability was determined by MTT assay. Cell apoptotic rate was detected by flow cytometry via double-staining of Annexin V-FITC/PI. Caspase 3 and NF-kappaB activity was determined by a Caspase 3 Activity Assay Kit or NF-kappaB p65 Transcription Factor Assay Kit, respectively. Bioinformatics prediction and luciferase reporter assay were used to investigate interactions between miR-128 and PPAR-gamma 3'UTR. RESULTS: MiR-128 expression was upregulated and PPAR-gamma expression was downregulated in plasma from AD patients and amyloid-beta (Abeta)-treated primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells. Inhibition of miR-128 decreased Abeta-mediated cytotoxicity through inactivation of NF-kappaB in MCN and N2a cells. Moreover, PPAR-gamma was a target of miR-128. PPAR-gamma upregulation attenuated Abeta-mediated cytotoxicity by inactivating NF-kappaB in MCN and N2a cells. Furthermore, PPAR-gamma downregulation was able to abolish the effect of anti-miR-128 on cytotoxicity and NF-kappaB activity in MCN and N2a cells. CONCLUSION: MiR-128 inhibitor decreased Abeta-mediated cytotoxicity by upregulating PPAR-gamma via inactivation of NF-kappaB in MCN and N2a cells, providing a new potential target in AD treatment.
30328325	29	34	Abeta	Gene	11820
30328325	44	56	Cytotoxicity	Disease	MESH:D064420
30328325	70	80	PPAR-gamma	Gene	19016
30328325	85	94	NF-kappaB	Gene	18033
30328325	119	124	Mouse	Species	10090
30328325	134	141	Neurons	CellLine	CVCL:U378
30328325	146	153	Neuro2a	CellLine	CVCL:0470
30328325	170	189	Alzheimer's disease	Disease	MESH:D000544
30328325	191	193	AD	Disease	MESH:D000544
30328325	229	234	death	Disease	MESH:D003643
30328325	308	334	neurodegenerative diseases	Disease	MESH:D019636
30328325	346	348	AD	Disease	MESH:D000544
30328325	410	412	AD	Disease	MESH:D000544
30328325	491	493	AD	Disease	MESH:D000544
30328325	565	613	peroxisome proliferator-activated receptor gamma	Gene	5468
30328325	615	625	PPAR-gamma	Gene	5468
30328325	706	716	PPAR-gamma	Gene	5468
30328325	804	807	MTT	Chemical	MESH:C070243
30328325	908	917	Caspase 3	Gene	836
30328325	922	931	NF-kappaB	Gene	4790
30328325	961	970	Caspase 3	Gene	836
30328325	993	1006	NF-kappaB p65	Gene	5970
30328325	1167	1177	PPAR-gamma	Gene	19016
30328325	1233	1243	PPAR-gamma	Gene	5468
30328325	1288	1290	AD	Disease	MESH:D000544
30328325	1291	1299	patients	Species	9606
30328325	1304	1316	amyloid-beta	Gene	351
30328325	1318	1323	Abeta	Gene	351
30328325	1341	1346	mouse	Species	10090
30328325	1356	1363	neurons	CellLine	CVCL:U378
30328325	1365	1368	MCN	CellLine	CVCL:U378
30328325	1374	1381	Neuro2a	CellLine	CVCL:0470
30328325	1383	1386	N2a	CellLine	CVCL:0470
30328325	1427	1432	Abeta	Gene	11820
30328325	1442	1454	cytotoxicity	Disease	MESH:D064420
30328325	1479	1488	NF-kappaB	Gene	18033
30328325	1492	1495	MCN	CellLine	CVCL:U378
30328325	1500	1503	N2a	CellLine	CVCL:0470
30328325	1521	1531	PPAR-gamma	Gene	19016
30328325	1557	1567	PPAR-gamma	Gene	19016
30328325	1592	1597	Abeta	Gene	11820
30328325	1607	1619	cytotoxicity	Disease	MESH:D064420
30328325	1636	1645	NF-kappaB	Gene	18033
30328325	1649	1652	MCN	CellLine	CVCL:U378
30328325	1657	1660	N2a	CellLine	CVCL:0470
30328325	1681	1691	PPAR-gamma	Gene	19016
30328325	1757	1769	cytotoxicity	Disease	MESH:D064420
30328325	1774	1783	NF-kappaB	Gene	18033
30328325	1796	1799	MCN	CellLine	CVCL:U378
30328325	1804	1807	N2a	CellLine	CVCL:0470
30328325	1855	1860	Abeta	Gene	11820
30328325	1870	1882	cytotoxicity	Disease	MESH:D064420
30328325	1899	1909	PPAR-gamma	Gene	19016
30328325	1930	1939	NF-kappaB	Gene	18033
30328325	1943	1946	MCN	CellLine	CVCL:U378
30328325	1951	1954	N2a	CellLine	CVCL:0470
30328325	1998	2000	AD	Disease	MESH:D000544
30328325	Negative_Correlation	MESH:D000544	5468
30328325	Association	MESH:D064420	11820
30328325	Association	11820	18033
30328325	Positive_Correlation	18033	19016
30328325	Negative_Correlation	351	5468
30328325	Association	MESH:D064420	19016
30328325	Association	MESH:D064420	18033
30328325	Association	11820	19016

